Business Context and Reporting Period
This Form 8-K is filed by DanDrit Biotech USA, Inc. (noted as Lunai Bioworks Inc. in metadata) on June 24, 2015. The report announces a change in the Company's fiscal year end from December 31 to June 30. Consequently, the new fiscal year runs from July 1 through June 30.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly administrative regarding the fiscal calendar change.
Material Changes
- Fiscal Year Change: The Company changed its fiscal year end from December 31 to June 30 effective June 24, 2015.
- Transition Period: The next Annual Report on Form 10-K will cover the transition period from December 31, 2015, through June 30, 2015.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the notification of the fiscal year amendment.
Key Facts for Investor Verification
- Verify the exact dates of the transition period (December 31, 2015, to June 30, 2015) for upcoming financial reporting.
- Confirm the filing of the subsequent Form 10-K to ensure it aligns with the new June 30 fiscal year end.
- Note that no financial performance data is included in this specific 8-K filing.